Cost-effectiveness analysis of chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection

Sexually Transmitted Diseases

Volumn 38, Issue 9, 2011, Pages 815-820

  Huang, Wei ^a   Gaydos, Charlotte A ^b   Barnes, Mathilda R ^b   Jett Goheen, Mary ^b   Blake, Diane R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION TREE; ENDOCERVICAL SWAB; FEMALE; HEALTH CARE COST; HUMAN; INTERNET; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PROBABILITY; SCREENING TEST; SENSITIVITY ANALYSIS; VAGINA SWAB;

AMBULATORY CARE FACILITIES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; COST-BENEFIT ANALYSIS; DECISION TREES; DNA, BACTERIAL; FEMALE; HUMANS; INTERNET; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREVALENCE; PUBLIC HEALTH; SELF ADMINISTRATION; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS;

EID: 80051781780     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31821b0f50     Document Type: Article

References (39)

1. CDC. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. Morb Mortal Wkly Rep 2009;58:362-365.
2. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55(RR-11):1-94.
3. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA 1991;266:2565-2569.
4. Yeh JM, Hook EW III, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis May 2003;30:369-378. (Pubitemid 36605484)
5. Lau C-Y, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: A meta-analysis of randomized clinical trials. Sex Transm Dis 2002;29:497-502. (Pubitemid 35001337)
6. Paavonen J, Puolakkainen M, Paukku M, et al. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 1998;92:292-298. (Pubitemid 28350866)
7. Blake DR, Maldeis N, Barnes MR, et al. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 2008;35:649-655.
8. Blake DR, Quinn TC, Gaydos CA. Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program. Sex Transm Dis 2008;35:91-101. (Pubitemid 351619359)
9. Miller WC, Hoffman IF, Owen-O'Dowd J, et al. Selective screening for chlamydial infection: Which criteria to use? Am J Prev Med 2000;18:115-122. (Pubitemid 30069945)
10. Mangione-Smith R, McGlynn EA, Hiatt L. Screening for chlamydia in adolescents and young women. Arch Pediatr Adolesc Med 2000;154:1108-1113.
11. Klausner JD. Websites and STD services. Sex Transm Dis 1999;26:548. (Pubitemid 29485348)
12. Graseck AS, Secura GM, Allsworth JE, et al. Home screening compared with clinic-based screening for sexually transmitted infections. Obstet Gynecol 2010;115:745-752.
13. Cook RL, Ostergaard L, Hillier SL, et al. Home screening for sexually transmitted diseases in high-risk young women: Randomised controlled trial. Sex Transm Infect 2007;83:286-291. (Pubitemid 47242507)
14. Gaydos CA, Barnes M, Aumakhan B, et al. Can e-technology through the Internet be used as a new tool to address the Chlamydia trachomatis epidemic by home sampling and vaginal swabs? Sex Transm Dis 2009;36:577-580.
15. Chernesky M, Freund GG, Hook E III, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North Am women by testing SurePath liquid-based Pap specimens in APTIMA assays. J Clin Microbiol 2007;45:2434-2438. (Pubitemid 47295470)
16. Chernesky M, Jang D, Portillo E, et al. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquidbased Pap samples. J Clin Microbiol 2007;45:2355-2358. (Pubitemid 47295458)
17. Chernesky M, Jang D, Smieja M, et al. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices. Sex Transm Dis 2009;36:581-583.
18. Gaydos CA, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 2003;41:304-309. (Pubitemid 36098592)
19. Masek BJ, Arora N, Quinn N, et al. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol 2009;47:1663-1667.
20. Moncada J, Schachter J, Hook EW III, et al. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: The infected patient standard reduces sensitivity of single site evaluation. Sex Transm Dis 2004;31:273-277. (Pubitemid 38542655)
21. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005;32:725-728. (Pubitemid 41752557)
22. Paavonen J, Kiviat N, Brunham RC, et al. Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol 1985;152:280-286. (Pubitemid 15049750)
23. Jones RB, Mammel JB, Shepard MK, et al. Recovery of Chlamydia trachomatis from the endometrium of women at risk for chlamydial infection. Am J Obstet Gynecol 1986;155:35-39. (Pubitemid 16100522)
24. Stamm WE, Guinan ME, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984;310:545-549. (Pubitemid 14193092)
25. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: Insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002;100:456-463. (Pubitemid 35246131)
26. Buchan H, Vessey M, Goldacre M, et al. Morbidity following pelvic inflammatory disease. Br J Obstet Gynaecol 1993;100:558-562. (Pubitemid 23186360)
27. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002;186:929-937.
28. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980;138(7 Pt 2):880-892. (Pubitemid 11198961)
29. Westrom L, Bengtsson LP, Mardh PA. Incidence, trends, and risks of ectopic pregnancy in a population of women. BMJ (Clin Res Ed) 1981;282:15-18. (Pubitemid 11167267)
30. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1, 844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:185-192.
31. Chandra A, Stephen EH. Infertility service use among US women: 1995 and 2002. Fertil Steril 2010;93:725-736.
32. Hirsch MB, Mosher WD. Characteristics of infertile women in the United States and their use of infertility services. Fertil Steril. 1987;47:618-625. (Pubitemid 17065625)
33. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007;147:89-96. (Pubitemid 351664612)
34. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004;291:2229-2236. (Pubitemid 38608172)
35. Bohm MK, Newman L, Satterwhite CL, et al. Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis 2010;37:131-136.
36. Sutton MY, Sternberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005;32:778-784. (Pubitemid 41752566)
37. Smith KJ, Cook RL, Ness RB. Cost comparisons between homeand clinic-based testing for sexually transmitted diseases in highrisk young women. Infect Dis Obstet Gynecol 2007;2007:62467.
38. Haggerty CL, Gottlieb SL, Taylor BD, et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 15 2010;201(suppl 2):S134-S155.
39. Wiesenfeld HC, Sweet RL, Ness RB, et al. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 2005;32:400-405. (Pubitemid 40875375)